eHealth Q2 2024 GAAP EPS $(1.33) Misses $(1.14) Estimate, Sales $65.856M Beat $55.024M Estimate
Portfolio Pulse from Benzinga Newsdesk
eHealth (NASDAQ:EHTH) reported Q2 2024 GAAP EPS of $(1.33), missing the $(1.14) estimate by 16.67%. However, sales of $65.856M beat the $55.024M estimate by 19.69%, despite a 1.37% decrease from the same period last year.
August 07, 2024 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
eHealth reported a Q2 2024 GAAP EPS of $(1.33), missing the $(1.14) estimate by 16.67%. However, sales of $65.856M beat the $55.024M estimate by 19.69%, despite a 1.37% decrease from the same period last year.
The mixed results, with a significant EPS miss but a notable sales beat, create a neutral short-term outlook. Investors may be concerned about the earnings miss but reassured by the strong sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100